 |
市場調査レポート
商品コード
1452818
遺伝子毒性検査の世界市場規模、シェア、成長分析：製品別、用途別 - 産業予測（2024～2031年）Global Genetic Toxicology Testing Market Size, Share, Growth Analysis, By Product(Reagents & Consumables, Assays), By Application(Pharmaceutical & Biotechnology, Food Industry) - Industry Forecast 2024-2031 |
||||||
| 遺伝子毒性検査の世界市場規模、シェア、成長分析：製品別、用途別 - 産業予測（2024～2031年） |
|
出版日: 2024年03月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の遺伝子毒性検査の市場規模は、2022年に13億1,000万米ドルとなり、2023年の14億8,000万米ドルから、2031年までには38億4,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは12.70%で成長する見通しです。
遺伝子毒性検査は、製薬、バイオテクノロジー、化学産業において重要な役割を果たしており、新薬、化学物質、消費者製品の安全性評価において基本的な要素となっています。この段階は、人の健康と環境の両方に対する潜在的リスクを徹底的に評価することを保証するものです。市場の重要性は、規制当局の監視の強化、検査手法の進歩、公衆衛生と安全性への関心の高まりにより、上昇傾向にあります。顕著な成長を促す要因としては、製薬・化学分野における研究開発活動の拡大、世界の保健衛生規制の厳格化、遺伝毒性物質への曝露による長期的影響の可能性に対する意識の高まりなどが挙げられます。従来の検査が不可欠であることに変わりはありませんが、in vitro小核アッセイ、in silicoモデリング、ハイスループットスクリーニング法などの革新的な技術がそれらを補完し、より迅速で正確、かつ費用対効果の高い検査を可能にしています。さらに、動物の使用を最小限に抑えるための代替検査法へのシフトは、倫理的配慮と規制要件に合致しており、非動物検査モデルの採用を促進しています。遺伝子毒性検査を専門とする開発業務受託機関など、市場の主要企業は、多様な検査サービスを提供することで、市場のダイナミックな状況に貢献しています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
遺伝子毒性検査の世界市場：製品別
- 市場概要
- 試薬・消耗品
- アッセイ
- サービス
遺伝子毒性検査の世界市場：用途別
- 市場概要
- 製薬・バイオテクノロジー
- 食品業界
- 化粧品産業
- その他
遺伝子毒性検査の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Covance Inc.（USA）
- Eurofins Scientific SE（Luxembourg）
- Charles River Laboratories International Inc.（USA）
- SGS SA（Switzerland）
- Merck KGaA（Germany）
- Laboratory Corporation of America Holdings（LabCorp）（USA）
- Thermo Fisher Scientific Inc.（USA）
- Toxikon Corporation（USA）
- WuXi AppTec（China）
- Genetic Toxicology Association（GTA）（USA）
- BioReliance Corporation（USA）
- Intertek Group plc（UK）
- Shanghai Medicilon Inc.（China）
- Bio-Rad Laboratories, Inc.（USA）
- MPI Research（USA）
- Cell Systems Corporation（USA）
- CeeTox Inc.（USA）
- Gentronix Ltd.（UK）
- LabGenius Limited（UK）
- Molecular Toxicology Inc.（USA）
- Ricerca Biosciences LLC（USA）
- ATCC（American Type Culture Collection）（USA）
- Coy Laboratory Products Inc.（USA）
- Promega Corporation（USA）
- Creative Bioarray（USA）
Global Genetic Toxicology Testing Market size was valued at USD 1.31 billion in 2022 and is poised to grow from USD 1.48 billion in 2023 to USD 3.84 billion by 2031, growing at a CAGR of 12.70% during the forecast period (2024-2031).
Genetic toxicology testing plays a crucial role in the pharmaceutical, biotechnology, and chemical industries, serving as a fundamental component in the safety assessment of new drugs, chemicals, and consumer products. This phase ensures a thorough evaluation of potential risks to both human health and the environment. The market's significance is on the rise due to heightened regulatory scrutiny, advancements in testing methodologies, and an increased focus on public health and safety. Factors driving its notable growth include expanding research and development activities in pharmaceutical and chemical sectors, stringent global health regulations, and a growing awareness of the potential long-term impacts of exposure to genotoxic substances. While traditional tests remain essential, innovative techniques such as in vitro micronucleus assays, in silico modeling, and high-throughput screening methods are complementing them, facilitating faster, more accurate, and cost-effective testing. Additionally, the shift towards alternative testing methods to minimize animal usage aligns with ethical considerations and regulatory requirements, fostering the adoption of non-animal testing models. Key players in the market, including contract research organizations specializing in genetic toxicology testing, contribute to its dynamic landscape by offering a diverse range of testing services.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genetic Toxicology Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Genetic Toxicology Testing Market Segmental Analysis
The global genetic toxicology testing market is segmented on the basis of Type, Product, Application and region. By Type, the market is segmented into In Vitro, In Vivo. By Product, the market is segmented into Reagents & Consumables, Assays, Services. By Application, the market is segmented into Pharmaceutical & Biotechnology, Food Industry, Cosmetics Industry, Other. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Genetic Toxicology Testing Market
The increasing recognition among individuals and healthcare professionals regarding the significance of genetic health and its consequences serves as a major catalyst. Genetic toxicology testing plays a crucial role in pinpointing potential hazards linked to exposure to diverse environmental elements like chemicals, medications, and pollutants. This, in turn, contributes to personalized healthcare and facilitates the implementation of preventive measures.
Restraints in the Global Genetic Toxicology Testing Market
Genetic toxicology testing delves into scrutinizing an individual's genetic data, giving rise to ethical considerations regarding privacy, consent, and the potential for data misuse. The meticulous management of genetic information, encompassing its collection, storage, and utilization, necessitates adherence to stringent privacy regulations. This cautious approach may pose a challenge to the broad acceptance and integration of genetic testing practices.
Market Trends of the Global Genetic Toxicology Testing Market
The market is undergoing a notable transition towards in vitro genetic toxicology testing techniques, supplanting traditional animal-based methods with cell-based assays. This shift is fueled by the benefits these assays provide, including diminished ethical concerns, quicker results, cost-effectiveness, and enhanced relevance to human biology. In vitro approaches like the Ames test, micronucleus assay, and Comet assay are increasingly popular for their capacity to furnish precise data on the genotoxicity and mutagenicity potential of substances. Regulatory bodies are actively endorsing the adoption of in vitro methods, amplifying their incorporation into the industry.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Genetic Toxicology Testing Market by Product
- Market Overview
- Reagents & Consumables
- Assays
- Services
Global Genetic Toxicology Testing Market by Application
- Market Overview
- Pharmaceutical & Biotechnology
- Food Industry
- Cosmetics Industry
- Other
Global Genetic Toxicology Testing Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Covance Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Charles River Laboratories International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SGS SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Laboratory Corporation of America Holdings (LabCorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Toxikon Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genetic Toxicology Association (GTA) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioReliance Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shanghai Medicilon Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MPI Research (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cell Systems Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CeeTox Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gentronix Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LabGenius Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Molecular Toxicology Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ricerca Biosciences LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ATCC (American Type Culture Collection) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Coy Laboratory Products Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creative Bioarray (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
